We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Pilot study compares HyBryte™ and Valchlor® effectiveness in treating CTCL, suggesting potential benefits.
ClinicalTrials.gov, NCT06149247; registered November 20, 2023.
No takes yet. Share an insight, caveat, or question.
Poligone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: